Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Hepatitis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    May 2025
  1. OWAIS M, Kumar D, Anjum A, Kumar J, et al
    Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
    PubMed    


  2. FATIMA N, Usmani WA
    Long-Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09119.
    PubMed     Abstract available


  3. PASTA A, Pieri G, Plaz Torres MC, Missale G, et al
    Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064.
    PubMed     Abstract available


    April 2025
  4. ELTHES BZ, Vitalis Z, Papp M, Tornai T, et al
    Long Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
    Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-09033.
    PubMed     Abstract available


    March 2025
  5. HABASH N, Absah I
    Hepatitis B Risk in Vaccinated Patients with Celiac Disease - Do Titers Matter?
    Dig Dis Sci. 2025 Mar 20. doi: 10.1007/s10620-025-08998.
    PubMed    


    February 2025
  6. SRINATH VBS, Shahid F, Saddique MN, Mumtaz H, et al
    Cholestatic Phenotype in Autoimmune Hepatitis: A Rare Presentation.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08927.
    PubMed    


  7. JOSSEN J, Lebwohl B, Soderling J, Duberg AS, et al
    No Increased Risk of Hepatitis B Virus Infection in Patients with Celiac Disease: A Population-Based Study.
    Dig Dis Sci. 2025 Feb 21. doi: 10.1007/s10620-025-08878.
    PubMed     Abstract available


  8. PAK K, Sachar R, Saab S
    Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States.
    Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909.
    PubMed     Abstract available


    November 2024
  9. DE LA TORRE SA JR, Morcos M, Saab S, Shetty A, et al
    Alcohol-Associated Hepatitis: Short- and Long-Term Management.
    Dig Dis Sci. 2024 Nov 22. doi: 10.1007/s10620-024-08705.
    PubMed     Abstract available


  10. CON D, Clayton-Chubb D, Tu S, Lubel JS, et al
    Predicting Immune Flares in Untreated Chronic Hepatitis B Patients Using Novel Risk Factors and the FLARE-B Score.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08746.
    PubMed     Abstract available


  11. XIAO Y, Shi M, Xiao J, Xie X, et al
    Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08736.
    PubMed     Abstract available


    September 2024
  12. RULE JA, Ajayi F, James LP, Tujios SR, et al
    Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose.
    Dig Dis Sci. 2024 Sep 2. doi: 10.1007/s10620-024-08602.
    PubMed     Abstract available


    July 2024
  13. MAKOVICH Z, Radosavljevic I, Chapyala S, Handley G, et al
    Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.
    Dig Dis Sci. 2024 Jul 11. doi: 10.1007/s10620-024-08541.
    PubMed     Abstract available


  14. CHANG CW, Hsu WF, Tseng KC, Chen CY, et al
    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08512.
    PubMed     Abstract available


    June 2024
  15. LEY D, Lazarus S, Forati AM, Farraye FA, et al
    High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy.
    Dig Dis Sci. 2024 Jun 21. doi: 10.1007/s10620-024-08527.
    PubMed     Abstract available


  16. HEALEY MA, Ramalingam G, Hang Y, Smirnova E, et al
    Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis.
    Dig Dis Sci. 2024 Jun 18. doi: 10.1007/s10620-024-08479.
    PubMed     Abstract available


    May 2024
  17. PAN CW, Guifarro D, Poudel A, Abboud Y, et al
    Racial Disparities in Alcoholic Hepatitis Hospitalizations in the United States: Trends, Outcomes, and Future Projections.
    Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08462.
    PubMed     Abstract available


    April 2024
  18. LEE DU, Bhowmick K, Kolachana S, Schuster K, et al
    Inpatient Cost Burdens of Treating Chronic Hepatitis B in US Hospitals: A Weighted Analysis of a National Database.
    Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08448.
    PubMed     Abstract available


  19. CHANG ML, Le PH, Chen WT, Chen TD, et al
    Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
    Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
    PubMed     Abstract available


  20. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    PubMed     Abstract available


    February 2024
  21. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    PubMed     Abstract available


  22. HUANG J, Cheng C, Li K, Zhu C, et al
    Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08258.
    PubMed     Abstract available


    December 2023
  23. POOLA S, Kratzer M, Sewell K, Tillmann HL, et al
    Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.
    Dig Dis Sci. 2023;68:4511-4520.
    PubMed     Abstract available


    November 2023
  24. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    PubMed     Abstract available


    October 2023
  25. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    PubMed     Abstract available


  26. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
    Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
    PubMed     Abstract available


  27. KILANI Y, Arshad I, Aldiabat M, Bhatija RR, et al
    Autoimmune Hepatitis and Obstetrical Outcomes: A Nationwide Assessment.
    Dig Dis Sci. 2023 Oct 10. doi: 10.1007/s10620-023-08129.
    PubMed     Abstract available


  28. EVON DM, Lin HS, Khalili M, Wahed AS, et al
    Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
    Dig Dis Sci. 2023 Oct 7. doi: 10.1007/s10620-023-08108.
    PubMed     Abstract available


    September 2023
  29. CZAJA AJ
    Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis.
    Dig Dis Sci. 2023 Sep 27. doi: 10.1007/s10620-023-08118.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.